POC MRI Helps Evaluate Intracerebral Hemorrhage
|
By MedImaging International staff writers Posted on 09 Sep 2021 |

Image: The Swoop low-field pMRI device (Photo courtesy of HyperFine Research)
A new study confirms that portable magnetic resonance imaging (pMRI) can scan for intracerebral hemorrhage (ICH) at the point-of-care (POC).
Researchers at Yale School of Medicine (New Haven, CT, USA) and Yale New Haven Hospital (YNHH; CT, USA) conducted a study involving 144 pMRI examinations (56 ICH, 48 acute ischemic stroke, 40 healthy controls) taken at the bedside at YNHH from July 2018 to November 2020, and compared them to traditional neuroimaging scans (non-contrast computerized tomography (CT) or 1.5/3 T MRI) to examine the efficacy of the Hyperfine Research (Guilford, CT, USA) Swoop low-field (0.064 T) pMRI device.
Two neuroradiologists evaluated all pMRI scans, with one ICH imaging core lab researcher reviewing the cases of disagreement. The raters correctly detected ICH in 45 of 56 cases (80.4%), and blood-negative cases were correctly identified in 85 of 88 cases (96.6%). Manually segmented hematoma volumes and ABC/2 formula for estimated volumes on pMRI correlated with conventional imaging volumes. Hematoma volumes measured on pMRI at discharge also correlated with manual and ABC/2 volumes. The study was published on August 25, 2021, in Nature Communications.
“There is no question this device can help save lives in resource-limited settings, such as rural hospitals or developing countries,” said senior author professor of neurology and neurosurgery Kevin Sheth, MD, of Yale School of Medicine. “There is also now a path to see how it can help in modern settings. It is of critical importance to continue to collect more data across a range of stroke characteristics so that we can maximize the potential benefit of this approach.”
The Swoop pMRI is a low-field system that features standard permanent magnets that require no power or cooling systems, producing an image using low-power radio waves and magnetic fields instead. The Swoop is controlled via a tablet device, using sequences and protocols selected from a playlist. As a result, the system is 10X lower in weight than current fixed conventional MRI systems, costs a fraction of the price, is highly portable, and plugs directly into a standard electrical wall outlet, with 35X lower power consumption.
Related Links:
Yale School of Medicine
Yale New Haven Hospital
Hyperfine Research
Researchers at Yale School of Medicine (New Haven, CT, USA) and Yale New Haven Hospital (YNHH; CT, USA) conducted a study involving 144 pMRI examinations (56 ICH, 48 acute ischemic stroke, 40 healthy controls) taken at the bedside at YNHH from July 2018 to November 2020, and compared them to traditional neuroimaging scans (non-contrast computerized tomography (CT) or 1.5/3 T MRI) to examine the efficacy of the Hyperfine Research (Guilford, CT, USA) Swoop low-field (0.064 T) pMRI device.
Two neuroradiologists evaluated all pMRI scans, with one ICH imaging core lab researcher reviewing the cases of disagreement. The raters correctly detected ICH in 45 of 56 cases (80.4%), and blood-negative cases were correctly identified in 85 of 88 cases (96.6%). Manually segmented hematoma volumes and ABC/2 formula for estimated volumes on pMRI correlated with conventional imaging volumes. Hematoma volumes measured on pMRI at discharge also correlated with manual and ABC/2 volumes. The study was published on August 25, 2021, in Nature Communications.
“There is no question this device can help save lives in resource-limited settings, such as rural hospitals or developing countries,” said senior author professor of neurology and neurosurgery Kevin Sheth, MD, of Yale School of Medicine. “There is also now a path to see how it can help in modern settings. It is of critical importance to continue to collect more data across a range of stroke characteristics so that we can maximize the potential benefit of this approach.”
The Swoop pMRI is a low-field system that features standard permanent magnets that require no power or cooling systems, producing an image using low-power radio waves and magnetic fields instead. The Swoop is controlled via a tablet device, using sequences and protocols selected from a playlist. As a result, the system is 10X lower in weight than current fixed conventional MRI systems, costs a fraction of the price, is highly portable, and plugs directly into a standard electrical wall outlet, with 35X lower power consumption.
Related Links:
Yale School of Medicine
Yale New Haven Hospital
Hyperfine Research
Latest MRI News
- AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
- Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
- AI System Improves Accuracy of Cardiac MRI Interpretation
- Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI
- Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
- AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
- AI MRI Tool Quantifies Muscle Fat to Assess Cardiometabolic Risk
- Advanced MRI Visualizes CSF Motion Changes After Mild Traumatic Brain Injury
- MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
- MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
- MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
- Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
- Advanced MRI System Detects Impaired Cardiac Oxygen Use in Minutes
- AI-Enhanced MRI Improves Image Quality in Arrhythmia Patients
- Ultra-Detailed Brain Atlas Enhances Early Detection of Neurological Disorders
- Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channelMultimodal AI Tool Combines CT and Health Records to Predict Heart Risk
Cardiovascular disease is a leading cause of death and an underrecognized risk for people treated for breast cancer. Cardiac complications can affect survival and quality of life. Clinicians need tools... Read more
AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







